Soleil Securities (Who?) -- Merck is a "Hold" Stock, Just Like Bristol Myers Squibb(?)

Okay -- so, whoever really founded Soleil Securities Group (it looks like most of the founders had stints at Goldman Sachs & Co. in common, on their resumes, but that was all more than ten years ago, in each case), they've started Merck out as a "Hold" at $36 -- not an "Accumulate"; not a "Buy" (but also not a "Reduce" or "Sell"):

. . . .Pharmaceutical Stocks: Soleil Securities starts Eli Lilly at Sell and has new Holds on both Bristol-Myers and Merck. . . .

Net-net -- it probably means almost. . . nothing.